Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study

Affiliations

¹ Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy.
² Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
³ Medical Oncology Unit, IRCSS-IRST, Meldola, Italy.
⁴ Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy.
⁵ Medical Oncology Unit, University of Pisa, Pisa, Italy.
⁶ Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy.
⁷ International Center for T1D, Department of Biomedical and Clinical Sciences, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi "L. Sacco", University of Milan, Milan, Italy.
⁸ Oncology Department, Polytechnic University of Marche, Ancona, Italy.
⁹ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
¹⁰ Medical Oncology Unit, University of Modena, Modena, Italy.
¹¹ Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy. marioscartozzi@gmail.com.
¹² Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario "Duilio Casula", Km 4500 Bivio per Sestu, S.S. 554, 09042, Monserrato, CA, Italy. marioscartozzi@gmail.com.

Published Erratum

Luca Faloppi et al. Target Oncol. 2020 Dec.

. 2020 Dec;15(6):801-802.

doi: 10.1007/s11523-020-00773-3.

¹ Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy.
² Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
³ Medical Oncology Unit, IRCSS-IRST, Meldola, Italy.
⁴ Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy.
⁵ Medical Oncology Unit, University of Pisa, Pisa, Italy.
⁶ Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy.
⁷ International Center for T1D, Department of Biomedical and Clinical Sciences, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi "L. Sacco", University of Milan, Milan, Italy.
⁸ Oncology Department, Polytechnic University of Marche, Ancona, Italy.
⁹ Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
¹⁰ Medical Oncology Unit, University of Modena, Modena, Italy.
¹¹ Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy. marioscartozzi@gmail.com.
¹² Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario "Duilio Casula", Km 4500 Bivio per Sestu, S.S. 554, 09042, Monserrato, CA, Italy. marioscartozzi@gmail.com.

Abstract

The listing of the author names and affiliations, which previously read.

Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study.
Faloppi L, Puzzoni M, Casadei Gardini A, Silvestris N, Masi G, Marisi G, Vivaldi C, Gadaleta CD, Ziranu P, Bianconi M, Loretelli C, Demurtas L, Lai E, Giampieri R, Galizia E, Ulivi P, Battelli N, Falcone A, Cascinu S, Scartozzi M. Faloppi L, et al. Target Oncol. 2020 Feb;15(1):115-126. doi: 10.1007/s11523-020-00698-x. Target Oncol. 2020. PMID: 32020517